The aseptic sampling market is segmented on the basis of type, technique, application, end user, and region. On the basis of type, the aseptic sampling market is segmented into manual aseptic sampling and automated aseptic sampling. In 2018, the manual aseptic sampling segment is expected to be the fastest-growing segment during the forecast period. Manual aseptic sampling has traditionally been used in pharmaceutical and biotechnology manufacturing. The introduction of single-use systems has helped drug manufacturers mitigate cross-contamination and cost issues. Moreover, manufacturers are reluctant to shift to automatic sampling, citing high costs and the need to train staff to handle the latter.

Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=9034729

On the basis of application, the aseptic sampling market is segmented into upstream process and downstream process. In 2018, the upstream process segment is expected to be the fastest-growing segment during the forecast period. Being the start of bioproduction, upstream processes form a key application area for aseptic sampling. Any contamination originating from the upstream process will be carried to the following processes and affect overall production, leading to failure. Their importance in this stage is the key factor supporting the use of aseptic sampling products.

On the basis of end user, the aseptic sampling market is segmented into pharmaceutical and biotechnology manufacturers, contract research and manufacturing organization, R&D departments, and other end users such as research academies and universities. The pharmaceutical and biotechnology manufacturers segment is expected to be the fastest-growing segment during the forecast period. The high growth can be attributed to the increasing demand for biopharmaceuticals and adoption of aseptic sampling in existing manufacturing facilities owing to their low capital cost and easy implementation.

APAC is expected to be the fastest-growing market for aseptic sampling during the forecast period. The high growth in this region can be attributed to the expansion of the biomanufacturing sector, increasing government support, developing R&D infrastructure, and growing outsourcing of bioproduction processes to this region from North America and Europe.

Rising income levels, expansion of pharmaceutical companies, and the presence of advanced medical infrastructure have led to the growth of the pharmaceutical market in countries like India, China, and Brazil. This growth in the target industries in emerging countries is expected to create potential growth opportunities for market players in the coming years.